IBDEI0VP ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15634,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,15634,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,15635,0)
 ;;=389.9^^89^911^39
 ;;^UTILITY(U,$J,358.3,15635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15635,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,15635,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,15635,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,15636,0)
 ;;=784.0^^89^911^38
 ;;^UTILITY(U,$J,358.3,15636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15636,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,15636,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,15636,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,15637,0)
 ;;=070.54^^89^911^40
 ;;^UTILITY(U,$J,358.3,15637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15637,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,15637,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,15637,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,15638,0)
 ;;=272.4^^89^911^41
 ;;^UTILITY(U,$J,358.3,15638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15638,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,15638,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,15638,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,15639,0)
 ;;=272.2^^89^911^42
 ;;^UTILITY(U,$J,358.3,15639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15639,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,15639,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,15639,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15640,0)
 ;;=401.9^^89^911^43
 ;;^UTILITY(U,$J,358.3,15640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15640,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,15640,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,15640,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,15641,0)
 ;;=244.9^^89^911^44
 ;;^UTILITY(U,$J,358.3,15641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15641,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,15641,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,15641,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,15642,0)
 ;;=790.21^^89^911^45
 ;;^UTILITY(U,$J,358.3,15642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15642,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,15642,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,15642,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,15643,0)
 ;;=790.5^^89^911^51
 ;;^UTILITY(U,$J,358.3,15643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15643,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,15643,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,15643,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,15644,0)
 ;;=724.2^^89^911^52
 ;;^UTILITY(U,$J,358.3,15644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15644,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,15644,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,15644,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,15645,0)
 ;;=412.^^89^911^56
 ;;^UTILITY(U,$J,358.3,15645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15645,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,15645,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,15645,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,15646,0)
 ;;=250.60^^89^911^58
 ;;^UTILITY(U,$J,358.3,15646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15646,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,15646,1,5,0)
 ;;=5^Neuropathy,Diabetic
 ;;^UTILITY(U,$J,358.3,15646,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,15647,0)
 ;;=V15.81^^89^911^59
 ;;^UTILITY(U,$J,358.3,15647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15647,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,15647,1,5,0)
 ;;=5^Noncompliance
 ;;^UTILITY(U,$J,358.3,15647,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,15648,0)
 ;;=278.00^^89^911^60
 ;;^UTILITY(U,$J,358.3,15648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15648,1,4,0)
 ;;=4^278.00
